153 related articles for article (PubMed ID: 11266426)
1. Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains.
Rodríguez-Hernández MJ; Cuberos L; Pichardo C; Caballero FJ; Moreno I; Jiménez-Mejías ME; García-Curiel A; Pachón J
J Antimicrob Chemother; 2001 Apr; 47(4):479-82. PubMed ID: 11266426
[TBL] [Abstract][Full Text] [Related]
2. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.
Pachón-Ibáñez ME; Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; García-Curiel A; Pichardo C; Jiménez L; Pachón J
Antimicrob Agents Chemother; 2010 Mar; 54(3):1165-72. PubMed ID: 20047914
[TBL] [Abstract][Full Text] [Related]
4. Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis.
Rodríguez-Hernández MJ; Jiménez-Mejias ME; Pichardo C; Cuberos L; García-Curiel A; Pachón J
Clin Microbiol Infect; 2004 Jun; 10(6):581-4. PubMed ID: 15191391
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Yıldırım MI; Tuğrul HM
Mikrobiyol Bul; 2011 Jul; 45(3):422-9. PubMed ID: 21935775
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J
Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Ardanuy C; Gudiol F
Antimicrob Agents Chemother; 2002 Jun; 46(6):1946-52. PubMed ID: 12019113
[TBL] [Abstract][Full Text] [Related]
9. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
Rodríguez-Hernández MJ; Pachón J; Pichardo C; Cuberos L; Ibáñez-Martínez J; García-Curiel A; Caballero FJ; Moreno I; Jiménez-Mejías ME
J Antimicrob Chemother; 2000 Apr; 45(4):493-501. PubMed ID: 10747827
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Shigemi A; Umezaki Y; Nakamura K; Ueno K; Morikawa N; Takeda Y
Int J Antimicrob Agents; 2014 Jun; 43(6):547-52. PubMed ID: 24796218
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia.
Pichardo C; Pachón-Ibañez ME; Docobo-Perez F; López-Rojas R; Jiménez-Mejías ME; Garcia-Curiel A; Pachon J
Eur J Clin Microbiol Infect Dis; 2010 May; 29(5):527-31. PubMed ID: 20182760
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
14. [Bactericide activity of sulbactam before bacteria belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex].
Villar HE; Laurino G; Hoffman M
Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):524-7. PubMed ID: 9035707
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains.
Pachón-Ibáñez ME; Docobo-Pérez F; Jiménez-Mejias ME; Ibáñez-Martínez J; García-Curiel A; Pichardo C; Pachón J
Eur J Clin Microbiol Infect Dis; 2011 Jul; 30(7):895-901. PubMed ID: 21336548
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pan-drug resistant Acinetobacter baumannii.
Lee CM; Lim HK; Liu CP; Tseng HK
Scand J Infect Dis; 2005; 37(3):195-9. PubMed ID: 15849052
[TBL] [Abstract][Full Text] [Related]
19. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.
Choi JY; Park YS; Cho CH; Park YS; Shin SY; Song YG; Yong D; Lee K; Kim JM
Clin Microbiol Infect; 2004 Dec; 10(12):1098-101. PubMed ID: 15606639
[TBL] [Abstract][Full Text] [Related]
20. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem.
Joly-Guillou ML; Wolff M; Pocidalo JJ; Walker F; Carbon C
Antimicrob Agents Chemother; 1997 Feb; 41(2):345-51. PubMed ID: 9021190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
